The V109G polymorphism in the p27 gene is associated with endometriosis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 145, Issue 2, 2009, Pages 180-183

  Camargo Kosugi, Cíntia M ^a   da Silva, Ismael D C G ^a   Sato, Hélio ^a   D'Amora, Paulo ^a   Carvalho, Cristina V ^a   Nogueira de Souza, Naiara C ^a   Girão, Manoel J C B ^a   Schor, Eduardo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endometriosis; p27; Polymorphism

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; BRAZIL; CODON; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; P27 GENE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 67650077196     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.04.027     Document Type: Article

References (30)

1. Montgomery G.W., Nyholt D.R., Zhao Z.Z., et al. The search for genes contributing to endometriosis risk. Hum Reprod Update 14 5 (2008) 447-457
2. Tempfer C.B., Simoni M., Destenaves B., and Fauser B.C. Functional genetic polymorphism and female reproductive disorders: part II-endometriosis. Hum Reprod Update 15 1 (2009) 97-118
3. Wenzl R., Kiesel L., Huber J.C., and Wieser F. Endometriosis: a genetic disease. Drugs Today 39 (2003) 961-972
4. Meresman G.F., Vighi S., Buquet R.A., Contreras-Ortiz O., Tesone M., and Rumi L.S. Apoptosis and expression of Bcl-2, Bax in eutopic endometrium from women with endometriosis. Fertil Steril 74 (2000) 760-766
5. MacLachlan T.K., Sang N., and Giordano A. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr 5 (1995) 127-156
6. Lloyd R.V., Erickson L.A., Jin L., et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154 (1999) 313-323
7. Schor E., da Silva I.D., Sato H., Baracat E.C., Girão M.J., and de Freitas V. P27(Kip1) is down-regulated in the endometrium of women with endometriosis. Fertil Steril (2008) [epub ahead of print]
8. Li G., Sturgis E.M., Wang L.E., et al. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma. Clin Cancer Res 10 (2004) 3996-4002
9. Zheng W.Q., Zheng J.M., Ma R., Meng F.F., and Ni C.R. Relationship between levels of Skp2 and P27 in breast carcinomas and possible role of Skp2 as targeted therapy. Steroids 70 (2005) 770-774
10. Matsuzaki S., Canis M., Murakami T., Dechelotte P., Bruhat M.A., and Okamura K. Expression of the cyclin-dependent kinase inhibitor p27Kip1 in eutopic endometrium and peritoneal endometriosis. Fertil Steril 75 5 (2001) 956-960
11. Claret F.X., Hibi M., Dhut S., Toda T., and Karin M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383 (1996) 453-457
12. Pagano M., Tam S.W., Theodoras A.M., et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269 (1995) 682-685
13. Tomoda K., Kubota Y., and Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398 (1999) 160-165
14. Polyak K., Kato J.Y., Solomon M.J., et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8 (1994) 9-22
15. Polyak K., Lee M.H., Erdjument-Bromage H., et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 (1994) 59-66
16. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., and Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 366 (1993) 701-704
17. Matsuoka S., Edwards M.C., Bai C., et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9 (1995) 650-662
18. Clurman B.E., and Porter P. New insights into the tumor suppression function of P27(kip1). Proc Natl Acad Sci 95 (1998) 15158-15160
19. Gollin S.M. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 23 (2001) 238-253
20. Hirai H., Roussel M.F., Kato J.Y., Ashmun R.A., and Sherr C.J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15 (1995) 2672-2681
21. Choi H.R., Tucker S.A., Huang Z., et al. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J Oncol 22 (2003) 409-414
22. Kuropkat C., Rudolph P., Frahm S.O., Parwaresch R., and Werner J.A. Proliferation marker Ki-S11-a prognostic indicator for squamous cell carcinoma of the hypopharynx. Virchows Arch 435 (1999) 590-595
23. Kawamata N., Morosetti R., Miller C.W., et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 55 (1995) 2266-2269
24. Mineta H., Miura K., Suzuki I., et al. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer 85 (1999) 1011-1017
25. Kudo Y., Takata T., Ogawa I., et al. Reduced expression of p27(Kip1) correlates with an early stage of cancer invasion in oral squamous cell carcinoma. Cancer Lett 151 (2000) 217-222
26. Catzavelos C., Bhattacharya N., Ung Y.C., et al. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med 3 (1997) 227-230
27. Ohashi Y., Sasano H., Yamaki H., Shizawa S., Shineha R., and Akaishi T. Cell cycle inhibitory protein p27 in esophageal squamous cell carcinoma. Anticancer Res 19 (1999) 1843-1848
28. Fredersdorf S., Burns J., Milne A.M., et al. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci 94 (1997) 6380-6385
29. Porter P.L., Malone K.E., Heagerty P.J., et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3 (1997) 222-225
30. Kip1 in estrogen-related endometrial adenocarcinomas. Clin Cancer Res 9 (2003) 5332-5338